Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer
Yunlong Lu, Xinyu Sheng, Haiping Hao, et al.
Pharmacological Research (2023) Vol. 190, pp. 106731-106731
Open Access | Times Cited: 20

Showing 20 citing articles:

Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors
Meng Rui Chang, Egor M. Matnurov, Chengnan Wu, et al.
Journal of the American Chemical Society (2025) Vol. 147, Iss. 9, pp. 7908-7920
Open Access | Times Cited: 2
A promising future of metal‐N‐heterocyclic carbene complexes in medicinal chemistry: The emerging bioorganometallic antitumor agents
Qian Zhao, Bo Han, Cheng Peng, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2194-2235
Closed Access | Times Cited: 13
Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis
Lu Yuan, Shanshan Wang, Mengya Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 424-437
Open Access | Times Cited: 10
Gold(I) N‐heterocyclic carbene (NHC) complexes containing 6‐mercaptopurine derivatives and their in vitro anticancer and anti‐inflammatory effects
Zdeněk Trávnı́ček, Ján Vančo, Michal Čajan, et al.
Applied Organometallic Chemistry (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 9
Selenium in cancer management: exploring the therapeutic potential
Liang He, Pengfei Zhang, Yulong Peng, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overview
Neha Bhatia, Shreejita Hazra, Suresh Thareja
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115422-115422
Closed Access | Times Cited: 17
Strategically engineered Au(I) complexes for orchestrated tumor eradication via chemo-phototherapy and induced immunogenic cell death
Na Feng, Zhen Peng, Xin Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Quinizarin Gold(I) N‐Heterocyclic Carbene Complexes with Synergistic Activity Against Anthracycline‐Resistant Leukaemia Cells: Synthesis and Biological Activity Studies
Axel Steinbrueck, Matthew L. Reback, Christoph Rumancev, et al.
Chemistry - A European Journal (2025)
Open Access
Metal-based immunogenic cell death inducers for cancer immunotherapy
Jun Zou, Meng Rui Chang, Nikita A. Kuznetsov, et al.
Chemical Science (2025)
Open Access
Recent advances in regulating the cell cycle through inhibiting CDKs for cancer treatment
Weijiao Chen, Xujie Zhuang, Yuanyuan Chen, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 3, pp. 286-298
Closed Access
Oxoisoaporphine Alkaloid Iridium(III) Derivative: An Immunogenic Cell Death Inducer That Engages the Autophagy-Dependent Regulator Cathepsin D
Lu Yuan, Feng-Yang Wang, Matthew S. Levine, et al.
Journal of the American Chemical Society (2025)
Closed Access
Targeting the crosstalk between estrogen receptors and membrane growth factor receptors in breast cancer treatment: Advances and opportunities
Shunchao Yan, Jiale Ji, Zhijie Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116615-116615
Open Access | Times Cited: 3
Discovery of novel quinoline scaffold selective estrogen receptor degraders (SERDs) for treatment of ER positive breast cancer with enhanced antiproliferative bioactivity through immunogenic cell death (ICD) effects
Yunlong Lu, Zhenlin Liang, Lijuan Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116534-116534
Closed Access | Times Cited: 3
Synthesis of palladium complexes containing benzimidazole core and their catalytic activities in direct C H functionalization of five-membered heterocyclic bioactive motifs
Nedra Touj, Donia Bensalah, Lamjed Mansour, et al.
Journal of Molecular Structure (2023) Vol. 1297, pp. 136885-136885
Closed Access | Times Cited: 6
Synthesis of palladium complexes containing benzimidazole core and their catalytic activities in direct arylation of heteroaromatic species
Sema Şeker, Öznur Doğan Ulu, Nevın Gürbüz, et al.
Journal of Coordination Chemistry (2024) Vol. 77, Iss. 5-6, pp. 434-447
Closed Access | Times Cited: 1
Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future
Jiaqi Yao, Yiran Tao, Zelin Hu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Insight on cytotoxic NHC gold(I) halide complexes evaluated in multifaceted culture systems
Vincenza De Gregorio, Alessandra La Pietra, Andrea Candela, et al.
Current Research in Toxicology (2024) Vol. 6, pp. 100174-100174
Open Access
Unveiling the cytotoxicity of a new gold(I) complex towards hepatocellular carcinoma by inhibiting TrxR activity
Yuan Wang, Haokun Yuan, Rui-Qin Fang, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access
Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects
Yang Wang, Rui Yang, Ying Xie, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
Drug discovery of N-methyl-pyrazole derivatives as potent selective estrogen receptor degrader (SERD) for the treatment of breast cancer
Rupeng Dai, Xueting Bao, Haiping Hao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116894-116894
Closed Access
Page 1

Scroll to top